Yeah in this particular announcement there appears to contain...

Yeah in this particular announcement there appears to contain conflicting information regarding when to expect the first assay results. In the bullet point executive summary at the top of the announcement it mentions late-February, but then in the body of the announcement itself it says mid-February.

In the most recent quarterly the company released (on the 30th of Jan '23) it also mentions mid-February. So my assumption was that mid-February was when it was initially planned to be ready for release to the market but was then delayed into late February. That said, we're now coming into mid-March with no announcement as of yet, so it does make me wonder.